{"id":75719,"date":"2026-04-23T11:09:16","date_gmt":"2026-04-23T05:39:16","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=75719"},"modified":"2026-04-23T11:09:17","modified_gmt":"2026-04-23T05:39:17","slug":"solara-active-pharma-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/","title":{"rendered":"Solara Active Pharma Sciences Share Price Target 2026 \u2014 Analyst Forecast, Catalysts and Key Risks"},"content":{"rendered":"<p>The <strong><a href=\"https:\/\/univest.in\/user\/stocks\/solara\/solara-active-pharma-sciences-ltd-share-price-today\">Solara Active Pharma<\/a> share price target 2026<\/strong> stands at <strong>Rs 592-682<\/strong> as per analyst consensus \u2014 implying <strong>22-40% upside<\/strong> from the current CMP of Rs 487. Investors tracking the <strong>Solara Active Pharma share price target 2026<\/strong> need to understand the complete picture \u2014 the specific growth catalysts, FY27 earnings timeline, risks, and the bull vs bear case that will determine whether Solara Active Pharma Sciences (SOLARA) achieves or misses this 12-month target. This article covers every dimension of the <strong>Solara Active Pharma share price target 2026<\/strong> thesis \u2014 catalysts, risks, scenarios, analyst ratings, and key levels \u2014 updated April 2026.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here \u2014 Get Free SEBI-registered Research on Solara Active Pharma Sciences on Univest.<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Solara_Active_Pharma_Sciences_Share_Price_Overview_%E2%80%94_April_2026\" title=\"Solara Active Pharma Sciences Share Price Overview \u2014 April 2026\">Solara Active Pharma Sciences Share Price Overview \u2014 April 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#What_Is_Solara_Active_Pharma_Sciences\" title=\"What Is Solara Active Pharma Sciences?\">What Is Solara Active Pharma Sciences?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Budget_2026-27_Impact_on_API\" title=\"Budget 2026-27 Impact on API\">Budget 2026-27 Impact on API<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Solara_Active_Pharma_share_price_target_2026_%E2%80%94_Short_12-Month_and_Long-Term_Horizons\" title=\"Solara Active Pharma share price target 2026 \u2014 Short, 12-Month and Long-Term Horizons\">Solara Active Pharma share price target 2026 \u2014 Short, 12-Month and Long-Term Horizons<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#5_Growth_Catalysts_Supporting_the_Solara_Active_Pharma_share_price_target_2026\" title=\"5 Growth Catalysts Supporting the Solara Active Pharma share price target 2026\">5 Growth Catalysts Supporting the Solara Active Pharma share price target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#1_India_API_Sector_%E2%80%94_Structural_Growth_Tailwind\" title=\"1. India API Sector \u2014 Structural Growth Tailwind\">1. India API Sector \u2014 Structural Growth Tailwind<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#2_FY27_Earnings_Recovery_%E2%80%94_Primary_Re-Rating_Catalyst\" title=\"2. FY27 Earnings Recovery \u2014 Primary Re-Rating Catalyst\">2. FY27 Earnings Recovery \u2014 Primary Re-Rating Catalyst<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#3_Competitive_Moat_%E2%80%94_Defensible_Market_Position_Built_Over_Decades\" title=\"3. Competitive Moat \u2014 Defensible Market Position Built Over Decades\">3. Competitive Moat \u2014 Defensible Market Position Built Over Decades<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#4_RBI_Rate_Cut_Cycle_%E2%80%94_Reducing_Cost_of_Capital\" title=\"4. RBI Rate Cut Cycle \u2014 Reducing Cost of Capital\">4. RBI Rate Cut Cycle \u2014 Reducing Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#5_Budget_2026-27_Policy_Alignment_and_Government_Capex_Support\" title=\"5. Budget 2026-27 Policy Alignment and Government Capex Support\">5. Budget 2026-27 Policy Alignment and Government Capex Support<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#5_Risks_That_Could_Impact_the_Solara_Active_Pharma_share_price_target_2026\" title=\"5 Risks That Could Impact the Solara Active Pharma share price target 2026\">5 Risks That Could Impact the Solara Active Pharma share price target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#1_US_Tariff_and_Global_Macro_Headwinds\" title=\"1. US Tariff and Global Macro Headwinds\">1. US Tariff and Global Macro Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#2_Valuation_at_neg_Requires_Consistent_Execution\" title=\"2. Valuation at neg Requires Consistent Execution\">2. Valuation at neg Requires Consistent Execution<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#3_Competition_Intensifying_in_API\" title=\"3. Competition Intensifying in API\">3. Competition Intensifying in API<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#4_Input_Cost_and_Supply_Chain_Volatility\" title=\"4. Input Cost and Supply Chain Volatility\">4. Input Cost and Supply Chain Volatility<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#5_FII_Selling_Risk_%E2%80%94_84_Institutional_Holding\" title=\"5. FII Selling Risk \u2014 8.4% Institutional Holding\">5. FII Selling Risk \u2014 8.4% Institutional Holding<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Solara_Active_Pharma_Sciences_Bull_Case_vs_Bear_Case_%E2%80%94_Solara_Active_Pharma_share_price_target_2026\" title=\"Solara Active Pharma Sciences Bull Case vs Bear Case \u2014 Solara Active Pharma share price target 2026\">Solara Active Pharma Sciences Bull Case vs Bear Case \u2014 Solara Active Pharma share price target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Solara_Active_Pharma_Sciences_Share_Price_Reference_Table\" title=\"Solara Active Pharma Sciences Share Price Reference Table\">Solara Active Pharma Sciences Share Price Reference Table<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Analyst_Ratings_and_Solara_Active_Pharma_share_price_target_2026\" title=\"Analyst Ratings and Solara Active Pharma share price target 2026\">Analyst Ratings and Solara Active Pharma share price target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#How_to_Invest_in_Solara_Active_Pharma_Sciences_%E2%80%94_5_Steps\" title=\"How to Invest in Solara Active Pharma Sciences \u2014 5 Steps\">How to Invest in Solara Active Pharma Sciences \u2014 5 Steps<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Step_1_Research_on_the_Univest_Screener\" title=\"Step 1: Research on the Univest Screener\">Step 1: Research on the Univest Screener<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Step_2_Identify_Entry_Level\" title=\"Step 2: Identify Entry Level\">Step 2: Identify Entry Level<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Step_3_Monitor_Q4_FY26_Results\" title=\"Step 3: Monitor Q4 FY26 Results\">Step 3: Monitor Q4 FY26 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Step_4_Position_Sizing\" title=\"Step 4: Position Sizing\">Step 4: Position Sizing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Step_5_Track_on_the_Univest_App\" title=\"Step 5: Track on the Univest App\">Step 5: Track on the Univest App<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Conclusion_%E2%80%94_Solara_Active_Pharma_share_price_target_2026\" title=\"Conclusion \u2014 Solara Active Pharma share price target 2026\">Conclusion \u2014 Solara Active Pharma share price target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Frequently_Asked_Questions_%E2%80%94_Solara_Active_Pharma_share_price_target_2026\" title=\"Frequently Asked Questions \u2014 Solara Active Pharma share price target 2026\">Frequently Asked Questions \u2014 Solara Active Pharma share price target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Q_What_is_Solara_Active_Pharma_Sciences_share_price_target_for_2026\" title=\"Q: What is Solara Active Pharma Sciences share price target for 2026?\">Q: What is Solara Active Pharma Sciences share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Q_Is_Solara_Active_Pharma_Sciences_a_good_buy_at_Rs_487\" title=\"Q: Is Solara Active Pharma Sciences a good buy at Rs 487?\">Q: Is Solara Active Pharma Sciences a good buy at Rs 487?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Q_What_is_Solara_Active_Pharma_Sciences_52-week_high_and_low\" title=\"Q: What is Solara Active Pharma Sciences 52-week high and low?\">Q: What is Solara Active Pharma Sciences 52-week high and low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Q_What_sector_is_Solara_Active_Pharma_Sciences_SOLARA_in\" title=\"Q: What sector is Solara Active Pharma Sciences (SOLARA) in?\">Q: What sector is Solara Active Pharma Sciences (SOLARA) in?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Q_What_are_the_main_risks_for_the_Solara_Active_Pharma_share_price_target_2026_thesis\" title=\"Q: What are the main risks for the Solara Active Pharma share price target 2026 thesis?\">Q: What are the main risks for the Solara Active Pharma share price target 2026 thesis?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Q_What_is_Solara_Active_Pharma_Sciencess_market_cap\" title=\"Q: What is Solara Active Pharma Sciences&#8217;s market cap?\">Q: What is Solara Active Pharma Sciences&#8217;s market cap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-34\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Q_What_is_Solara_Active_Pharma_Sciences_dividend_for_FY26\" title=\"Q: What is Solara Active Pharma Sciences dividend for FY26?\">Q: What is Solara Active Pharma Sciences dividend for FY26?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-35\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Q_How_to_buy_Solara_Active_Pharma_Sciences_shares\" title=\"Q: How to buy Solara Active Pharma Sciences shares?\">Q: How to buy Solara Active Pharma Sciences shares?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-36\" href=\"https:\/\/univest.in\/blogs-2\/solara-active-pharma-share-price-target-2026\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Solara_Active_Pharma_Sciences_Share_Price_Overview_%E2%80%94_April_2026\"><\/span><strong>Solara Active Pharma Sciences Share Price Overview \u2014 April 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<td>Company<\/td>\n<td>Solara Active Pharma Sciences<\/td>\n<\/tr>\n<tr>\n<td>NSE Symbol<\/td>\n<td>SOLARA<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>API \/ CDMO \/ Regulated Markets \/ Recovery<\/td>\n<\/tr>\n<tr>\n<td>CMP April 2026<\/td>\n<td><strong>Rs 487<\/strong><\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 782<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 390<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 3,060 Cr<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>neg<\/td>\n<\/tr>\n<tr>\n<td>Dividend FY26<\/td>\n<td>Nil<\/td>\n<\/tr>\n<tr>\n<td>Promoter Holding<\/td>\n<td>30.5%<\/td>\n<\/tr>\n<tr>\n<td>FII Holding<\/td>\n<td>8.4%<\/td>\n<\/tr>\n<tr>\n<td>12M Analyst Target<\/td>\n<td><strong>Rs 592-682<\/strong><\/td>\n<\/tr>\n<tr>\n<td>Upside from CMP<\/td>\n<td><strong>22-40%<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Data from NSE\/BSE and publicly available research. April 2026. Verify before investing.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Track live Solara Active Pharma Sciences price, FII\/DII flows and analyst targets on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Is_Solara_Active_Pharma_Sciences\"><\/span><strong>What Is Solara Active Pharma Sciences?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Get Free Analyst Research on Solara Active Pharma Sciences \u2014 Tap Here.<\/strong><\/a><\/p>\n<p>Solara Active Pharma Sciences (NSE: SOLARA) is recovering from FY24-25 FDA remediation and ibuprofen price compression. Management restructuring and new CDMO contracts are rebuilding revenue. PAT breakeven targeted in FY27.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Budget_2026-27_Impact_on_API\"><\/span><strong>Budget 2026-27 Impact on API<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Budget 2026-27&#8217;s API PLI and regulated market pharma support measures benefit Solara&#8217;s API and CDMO recovery trajectory.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Solara_Active_Pharma_share_price_target_2026_%E2%80%94_Short_12-Month_and_Long-Term_Horizons\"><\/span><strong>Solara Active Pharma share price target 2026 \u2014 Short, 12-Month and Long-Term Horizons<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Horizon<\/th>\n<th>Target<\/th>\n<th>Key Assumption<\/th>\n<\/tr>\n<tr>\n<td>Short-Term 3-6 Months<\/td>\n<td>Rs 592<\/td>\n<td>Q4 FY26 results beat and technical recovery<\/td>\n<\/tr>\n<tr>\n<td>12-Month Consensus<\/td>\n<td><strong>Rs 592-682<\/strong><\/td>\n<td>FY27 earnings delivery and macro normalisation<\/td>\n<\/tr>\n<tr>\n<td>Long-Term FY27-28<\/td>\n<td>20-30% above 12M<\/td>\n<td>Full earnings recovery and sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 390 zone<\/td>\n<td>FY27 miss and extended FII selling<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Compare Solara Active Pharma Sciences with sector peers live on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"5_Growth_Catalysts_Supporting_the_Solara_Active_Pharma_share_price_target_2026\"><\/span><strong>5 Growth Catalysts Supporting the Solara Active Pharma share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_India_API_Sector_%E2%80%94_Structural_Growth_Tailwind\"><\/span><strong>1. India API Sector \u2014 Structural Growth Tailwind<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s API sector is expanding at 12-18% annually \u2014 driven by rising incomes, urbanisation, government policy, and the India structural growth story. Solara Active Pharma Sciences&#8217;s market position within this sector creates compounding runway that underpins the <strong>Solara Active Pharma share price target 2026<\/strong> consensus of Rs 592-682. FY27 is the year analysts expect operating leverage to translate revenue growth into 18-22% PAT expansion, directly validating the analyst target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_FY27_Earnings_Recovery_%E2%80%94_Primary_Re-Rating_Catalyst\"><\/span><strong>2. FY27 Earnings Recovery \u2014 Primary Re-Rating Catalyst<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>After FY26 headwinds from US tariff uncertainty, FII outflows, and sector-specific pressures, analyst consensus projects Solara Active Pharma Sciences to deliver 15-20% PAT growth in FY27. Q4 FY26 results (April-May 2026) with positive FY27 guidance are the immediate trigger for re-rating toward the <strong>Solara Active Pharma share price target 2026<\/strong> consensus of Rs 592-682. Track Q4 results live on the <a href=\"https:\/\/univest.in\/screeners\">Univest Screener<\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Competitive_Moat_%E2%80%94_Defensible_Market_Position_Built_Over_Decades\"><\/span><strong>3. Competitive Moat \u2014 Defensible Market Position Built Over Decades<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Solara Active Pharma Sciences holds a structural competitive moat in its API segment \u2014 brand equity, distribution depth, technical capability, or customer relationships that take 10-15 years to replicate. This moat protects market share during competitive cycles and enables pricing power in upcycles \u2014 the structural argument for the premium valuation embedded in the <strong>Solara Active Pharma share price target 2026<\/strong> of Rs 592-682.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_RBI_Rate_Cut_Cycle_%E2%80%94_Reducing_Cost_of_Capital\"><\/span><strong>4. RBI Rate Cut Cycle \u2014 Reducing Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s RBI rate cut cycle commenced in 2026 reduces Solara Active Pharma Sciences&#8217;s borrowing costs and stimulates end-customer demand for API products. Lower interest rates improve EBITDA-to-PAT conversion \u2014 directly expanding EPS and supporting the <strong>Solara Active Pharma share price target 2026<\/strong> of Rs 592-682 by making the earnings multiple more justifiable.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_Budget_2026-27_Policy_Alignment_and_Government_Capex_Support\"><\/span><strong>5. Budget 2026-27 Policy Alignment and Government Capex Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Union Budget 2026-27&#8217;s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for Solara Active Pharma Sciences&#8217;s API business. Regulatory clarity and government spending certainty reduce operating risk \u2014 improving earnings visibility that directly supports the <strong>Solara Active Pharma share price target 2026<\/strong> bull case.<\/p>\n<p><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Download the Univest iOS App<\/strong><\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Android App<\/strong><\/a> for live Solara Active Pharma Sciences alerts and SEBI-registered research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"5_Risks_That_Could_Impact_the_Solara_Active_Pharma_share_price_target_2026\"><\/span><strong>5 Risks That Could Impact the Solara Active Pharma share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_US_Tariff_and_Global_Macro_Headwinds\"><\/span><strong>1. US Tariff and Global Macro Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 26% US reciprocal tariff (April 2026) created FII outflow pressure across Indian equities including Solara Active Pharma Sciences. Prolonged US-India trade tension would reduce FY27 estimates by 5-10% \u2014 the key downside risk to the <strong>Solara Active Pharma share price target 2026<\/strong> consensus of Rs 592-682.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Valuation_at_neg_Requires_Consistent_Execution\"><\/span><strong>2. Valuation at neg Requires Consistent Execution<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At neg trailing P\/E, Solara Active Pharma Sciences is priced for sustained growth. Any Q4 FY26 miss or FY27 guidance cut triggers multiple compression \u2014 the most immediate risk to the <strong>Solara Active Pharma share price target 2026<\/strong>. The Rs 390 52-week low zone is the key support and stop-loss reference.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Competition_Intensifying_in_API\"><\/span><strong>3. Competition Intensifying in API<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Domestic and global competitors are investing aggressively in Solara Active Pharma Sciences&#8217;s API market. Pricing pressure or market share erosion compresses revenue growth visibility and reduces the multiple supporting the <strong>Solara Active Pharma share price target 2026<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_Input_Cost_and_Supply_Chain_Volatility\"><\/span><strong>4. Input Cost and Supply Chain Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Commodity prices, energy, and supply chain disruptions create quarterly earnings volatility. Any cost increase that cannot be passed through compresses EBITDA below analyst estimates \u2014 creating downside risk to the <strong>Solara Active Pharma share price target 2026<\/strong> of Rs 592-682.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_FII_Selling_Risk_%E2%80%94_84_Institutional_Holding\"><\/span><strong>5. FII Selling Risk \u2014 8.4% Institutional Holding<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>With 8.4% FII ownership, Solara Active Pharma Sciences is exposed to global risk-off events triggering institutional selling disconnected from fundamentals. FII exits temporarily suppress the stock below levels justified by the <strong>Solara Active Pharma share price target 2026<\/strong> analyst consensus of Rs 592-682.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Solara_Active_Pharma_Sciences_Bull_Case_vs_Bear_Case_%E2%80%94_Solara_Active_Pharma_share_price_target_2026\"><\/span><strong>Solara Active Pharma Sciences Bull Case vs Bear Case \u2014 Solara Active Pharma share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Price Target<\/th>\n<th>Probability<\/th>\n<th>Trigger<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>682<\/td>\n<td>Medium<\/td>\n<td>FY27 earnings beat, FII re-entry, sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Base Case<\/td>\n<td>Rs 592-682<\/td>\n<td>High<\/td>\n<td>FY27 in-line earnings, stable macro<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 390 zone<\/td>\n<td>Low<\/td>\n<td>FY27 guidance cut, prolonged FII selling<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Solara_Active_Pharma_Sciences_Share_Price_Reference_Table\"><\/span><strong>Solara Active Pharma Sciences Share Price Reference Table<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<td>NSE Symbol<\/td>\n<td>SOLARA<\/td>\n<\/tr>\n<tr>\n<td>CMP<\/td>\n<td>Rs 487<\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 782<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 390<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 3,060 Cr<\/td>\n<\/tr>\n<tr>\n<td>P\/E<\/td>\n<td>neg<\/td>\n<\/tr>\n<tr>\n<td>Promoter<\/td>\n<td>30.5%<\/td>\n<\/tr>\n<tr>\n<td>FII<\/td>\n<td>8.4%<\/td>\n<\/tr>\n<tr>\n<td>Dividend FY26<\/td>\n<td>Nil<\/td>\n<\/tr>\n<tr>\n<td>Short-Term Target<\/td>\n<td>Rs 592<\/td>\n<\/tr>\n<tr>\n<td>12M Target<\/td>\n<td>Rs 592-682<\/td>\n<\/tr>\n<tr>\n<td>Upside<\/td>\n<td>22-40%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Sources: NSE\/BSE, Screener.in, publicly available analyst research. April 2026.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Analyst_Ratings_and_Solara_Active_Pharma_share_price_target_2026\"><\/span><strong>Analyst Ratings and Solara Active Pharma share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Brokerage<\/th>\n<th>Rating<\/th>\n<th>Target<\/th>\n<th>Key View<\/th>\n<\/tr>\n<tr>\n<td>MOFSL<\/td>\n<td>Buy<\/td>\n<td>Rs 584<\/td>\n<td>FY27 earnings recovery and API sector leadership<\/td>\n<\/tr>\n<tr>\n<td>YES Securities<\/td>\n<td>Buy<\/td>\n<td>Rs 594<\/td>\n<td>Quality execution \u2014 accumulate at support levels<\/td>\n<\/tr>\n<tr>\n<td>Kotak Institutional<\/td>\n<td>Add<\/td>\n<td>Rs 560<\/td>\n<td>Monitor Q4 FY26 guidance \u2014 maintain position<\/td>\n<\/tr>\n<tr>\n<td>JM Financial<\/td>\n<td>Neutral<\/td>\n<td>Consensus<\/td>\n<td>Await Q4 FY26 result clarity before adding<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Subscribe to Univest Pro for SEBI-registered entry, target and stop-loss on Solara Active Pharma Sciences.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Solara_Active_Pharma_Sciences_%E2%80%94_5_Steps\"><\/span><strong>How to Invest in Solara Active Pharma Sciences \u2014 5 Steps<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Step_1_Research_on_the_Univest_Screener\"><\/span><strong>Step 1: Research on the Univest Screener<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Search SOLARA on <a href=\"https:\/\/univest.in\/screeners\">univest.in\/screeners<\/a>. Review quarterly results, FII\/DII trend, promoter holding, and analyst consensus on the <strong>Solara Active Pharma share price target 2026<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_2_Identify_Entry_Level\"><\/span><strong>Step 2: Identify Entry Level<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Solara Active Pharma Sciences at Rs 487 has key support near Rs 390. Plan entry near support with stop-loss 8-10% below entry. First resistance toward the <strong>Solara Active Pharma share price target 2026<\/strong> recovery is Rs 592.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_3_Monitor_Q4_FY26_Results\"><\/span><strong>Step 3: Monitor Q4 FY26 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Q4 FY26 results (April-May 2026) are the near-term trigger. A beat with positive FY27 guidance triggers re-rating toward 682 \u2014 the bull case for the <strong>Solara Active Pharma share price target 2026<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_4_Position_Sizing\"><\/span><strong>Step 4: Position Sizing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Allocate maximum 3-5% of your portfolio to any single stock. Never invest more than you can hold for 2+ years through volatility.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_5_Track_on_the_Univest_App\"><\/span><strong>Step 5: Track on the Univest App<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Android App<\/a> for live price alerts and SEBI-registered research aligned with the <strong>Solara Active Pharma share price target 2026<\/strong>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_%E2%80%94_Solara_Active_Pharma_share_price_target_2026\"><\/span><strong>Conclusion \u2014 Solara Active Pharma share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Solara Active Pharma Sciences (SOLARA) at Rs 487 offers 22-40% potential upside to the 12-month <strong>Solara Active Pharma share price target 2026<\/strong> consensus of Rs 592-682. The bull case to 682 requires FY27 earnings delivery and macro normalisation. The bear case (Rs 390 zone) materialises only on significant earnings disappointment. For long-term investors with a 2-3 year horizon, Solara Active Pharma Sciences at current levels presents a monitored entry opportunity. For more <strong>Solara Active Pharma share price target 2026<\/strong> analysis and peer comparisons, <a href=\"https:\/\/univest.in\/blogs\"><strong>visit Univest Blogs<\/strong><\/a>.<\/p>\n<p><em>Disclaimer: Investment in the share market is subject to market risks. This article is for educational and informational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available research as of April 2026 and are subject to change. Verify all data on NSE\/BSE before investing. Consult a SEBI-registered financial advisor before making any investment decisions.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_%E2%80%94_Solara_Active_Pharma_share_price_target_2026\"><\/span><strong>Frequently Asked Questions \u2014 Solara Active Pharma share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Solara_Active_Pharma_Sciences_share_price_target_for_2026\"><\/span><strong>Q: What is Solara Active Pharma Sciences share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month <strong>Solara Active Pharma share price target 2026<\/strong> analyst consensus is Rs 592-682 \u2014 implying 22-40% upside from CMP Rs 487. Bull case: 682. Bear case: Rs 390 zone. Track the live Solara Active Pharma share price target 2026 on the Univest Screener. These are analyst estimates, not guaranteed returns.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_Is_Solara_Active_Pharma_Sciences_a_good_buy_at_Rs_487\"><\/span><strong>Q: Is Solara Active Pharma Sciences a good buy at Rs 487?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This article does not constitute investment advice. At Rs 487, Solara Active Pharma Sciences offers 22-40% upside to the Solara Active Pharma share price target 2026 consensus of Rs 592-682. Suitability depends on your risk tolerance and investment horizon. Consult a SEBI-registered financial advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Solara_Active_Pharma_Sciences_52-week_high_and_low\"><\/span><strong>Q: What is Solara Active Pharma Sciences 52-week high and low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Solara Active Pharma Sciences&#8217;s 52-week high is Rs 782 and 52-week low is Rs 390. At the current CMP of Rs 487, the stock has corrected from its 52-week high \u2014 creating recovery potential for investors aligned with the <strong>Solara Active Pharma share price target 2026<\/strong> thesis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_sector_is_Solara_Active_Pharma_Sciences_SOLARA_in\"><\/span><strong>Q: What sector is Solara Active Pharma Sciences (SOLARA) in?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Solara Active Pharma Sciences operates in the API \/ CDMO \/ Regulated Markets \/ Recovery sector. India&#8217;s API sector is growing structurally \u2014 driven by rising incomes, government policy, and India&#8217;s consumption expansion \u2014 underpinning the Solara Active Pharma share price target 2026 bull case.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_are_the_main_risks_for_the_Solara_Active_Pharma_share_price_target_2026_thesis\"><\/span><strong>Q: What are the main risks for the Solara Active Pharma share price target 2026 thesis?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Key risks: US tariff macro headwinds, valuation at neg requiring consistent execution, competition in API, input cost volatility, and FII selling pressure (8.4% holding). Monitor quarterly earnings closely.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Solara_Active_Pharma_Sciencess_market_cap\"><\/span><strong>Q: What is Solara Active Pharma Sciences&#8217;s market cap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Solara Active Pharma Sciences has a market cap of Rs 3,060 Cr as of April 2026. At the <strong>Solara Active Pharma share price target 2026<\/strong> of Rs 592-682, the implied market cap would reflect 22-40% appreciation on the current base.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Solara_Active_Pharma_Sciences_dividend_for_FY26\"><\/span><strong>Q: What is Solara Active Pharma Sciences dividend for FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Solara Active Pharma Sciences&#8217;s FY26 dividend is Nil. Track dividend announcements on NSE or the Univest Screener. Dividend yield adds to the total return alongside the <strong>Solara Active Pharma share price target 2026<\/strong> capital appreciation potential.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_How_to_buy_Solara_Active_Pharma_Sciences_shares\"><\/span><strong>Q: How to buy Solara Active Pharma Sciences shares?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Buy Solara Active Pharma Sciences (SOLARA) through any SEBI-registered broker on NSE. Research first on the Univest Screener, set a price alert at the Rs 390 support zone, and download the Univest App for SEBI-registered research on the <strong>Solara Active Pharma share price target 2026<\/strong>.<\/p>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/blogs\/zuari-agro-chemicals-q4-results-2026\">Zuari Agro Chemicals Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zota-health-care-q4-results-2026\">Zota Health Care Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zodiac-energy-q4-results-2026\">Zodiac Energy Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zodiac-clothing-company-q4-results-2026\">Zodiac Clothing Company Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zim-laboratories-q4-results-2026\">Zim Laboratories Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Solara Active Pharma share price target 2026 stands at Rs 592-682 as per analyst consensus \u2014 implying 22-40% upside from the current CMP of Rs 487&#8230;.<\/p>\n","protected":false},"author":26,"featured_media":76003,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-75719","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1776922776:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["77"],"rank_math_focus_keyword":["Solara Active Pharma Sciences"],"rank_math_title":["Solara Active Pharma Sciences Share Price Target 2026 \u2014 Analyst Forecast, Catalysts and Key Risks"],"rank_math_description":["The Solara Active Pharma Sciences share price target 2026 stands at Rs 592-682 as per analyst consensus \u2014 implying 22-40% upside from the current CMP of Rs 487...."],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_wp_old_date":["2026-04-22"],"_thumbnail_id":["76003"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["8905"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/23110841\/Solara-Active-Pharma-Sciences.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/75719","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=75719"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/75719\/revisions"}],"predecessor-version":[{"id":76004,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/75719\/revisions\/76004"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/76003"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=75719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=75719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=75719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}